A small proportion of veterans who went from a metered-dose inhaler to a dry-powder inhaler had to revert to the metered-dose ...

Those receiving budesonide-glycopyrrolate-formoterol compared with fluticasone-umeclidinium-vilanterol had a higher risk for a first moderate COPD exacerbation (hazard ratio, 1.07; 95 percent ...

New medical therapies are needed to improve walking performance and to prevent the adverse outcomes associated with PAD-related functional impairment such as mobility loss and the ability to continue ...

Meanwhile, Pharmac's decision to fund the budesonide, glycopyrronium and formoterol aerosol inhaler is expected to help 5000 New Zealanders with COPD in the first year of funding, rising to 16,000 ...

Objectives: To compare the efficacy and tolerability of formoterol (12 or 24µg twice daily) alone with combined ipratropium bromide and fenoterol in the treatment of chronic obstructive pulmonary ...